Clinical Trials Logo

Filter by:
  • Active, not recruiting  
  • Page [1] ·  Next »
NCT ID: NCT06408610 Active, not recruiting - Obesity Clinical Trials

Moderate Continuous Versus High Interval Intensity Training on Gut Dysbiosis and GLP1 Hormone in IBS

Start date: May 1, 2024
Phase: N/A
Study type: Interventional

investigating the response of gut bacteria via measuring short chain fatty acids and Glucagon like peptide hormone to two different modes of exercises in pre-diabetic, obese patients with irritable bowel syndrome. It will be hypothesized that there will be no significant difference between the moderate continuous versus high interval intensity training on gut dysbiosis and glucagon like peptide hormone in irritable bowel syndrome.

NCT ID: NCT06406335 Active, not recruiting - ADHD Clinical Trials

Impact of A Multidimensional Health Education Program on Attention Deficit Hyperactivity Disorder (ADHD)

ADHD
Start date: February 23, 2024
Phase: N/A
Study type: Interventional

To measure the impact of a multidimensional health education program on patients' adherence to the healthy life style and behavioral therapy , and to correlate it with severity of ADHD symptoms

NCT ID: NCT06404541 Active, not recruiting - Dry Eye Syndromes Clinical Trials

A Comparative Study Between Preservative With Benzalkonium Chloride vs Preservative Free Eye Drops on the Ocular Surface

Start date: January 10, 2024
Phase: Phase 4
Study type: Interventional

study the effect of different concentrations of benzalkonium chloride on the ocular surface of non-dry-eyed patients post cataract surgery.

NCT ID: NCT06400355 Active, not recruiting - Clinical trials for Orthognathic Surgery

Effect of Mannitol on Recovery Pattern After Orthognathic Surgery

Start date: March 1, 2024
Phase: N/A
Study type: Interventional

The aim of this study is to test, whether mannitol infusion in different doses will affect recovery pattern? the investigators hypothesized that infusion of mannitol in doses of 0.5 gm/kg before recovery from anesthesia after orthognathic surgery shortens patients' recovery time, and improves recovery quality, as well as postoperative cognitive function better.

NCT ID: NCT06400082 Active, not recruiting - Wound Complication Clinical Trials

Topical Insulin for Postoperative Wound Healing

Start date: April 16, 2023
Phase: N/A
Study type: Interventional

This study aimed to investigate the potential effect of applying topical insulin therapy on the management and healing of postoperative wounds in patients known with type 2 diabetes mellitus (T2DM) and in a parallel group without diabetes. Investigators also studied the effect of topical insulin therapy on the expression of e-cadherin and Ki67, as markers for cellular proliferation and wound repair. The levels of IL-6 and the H2O2-induced DNA damage product, 8-hydroxy-2'-deoxyguanosine (8-OHdG), were assessed as markers for inflammation and oxidative stress. Finally, histomorphological assessment of skin biopsies was also carried out.

NCT ID: NCT06395116 Active, not recruiting - Clinical trials for Inflammatory Response

Microbial Adhesion and Biofilm Formation on Denture Base Materials

Start date: January 20, 2023
Phase:
Study type: Observational

Polymethylmethacrylate (PMMA) has been the material of choice for fabricating complete dentures for more than 80 years now.(1,2) As a material it is easy to handle and can be easily repaired and polished. PMMA while being a low-cost material has good esthetics. Some disadvantages of PMMA as a material are surface roughness and porosities which lead to staining, plaque accumulation and bacterial adhesion over time. Among the various factors that can influence microbial attachment to surfaces, surface roughness, hydrophilicity and free surface energy of PMMA are most important. Carboxylate and methyl ester groups found in PMMA make it a very hydrophilic material with a large amount of free surface energy. Despite the influence of the chemical composition, processing methods play the most important role in developing surface roughness.

NCT ID: NCT06371885 Active, not recruiting - Clinical trials for Carpal Tunnel Syndrome

Shock Wave on Pillar Pain After Carpal Tunnel Release in Hand Burn

Start date: August 10, 2023
Phase: N/A
Study type: Interventional

"In burn cases, the reported causes of CTS are increased volume of carpal tunnel content due to edema and synovitis, wrist hyperextension, tight dressing, fibrosis, and direct burn to the nerve. There are two types of pain that occur in the palm of the hand after carpal tunnel surgery: incisional pain and pillar pain. The incision pain typically only lasts for a few days or weeks after surgery, while the pillar pain occurs on the sides of the incision in the thicker parts of the palm, called the thenar and hypothenar eminences. This is where the transverse ligament attaches to the carpal bones, forming the carpal tunnel. So, in this study we will find out if shock wave therapy has therapeutic effect on pillar pain after carpal tunnel release in hand burn.

NCT ID: NCT06370650 Active, not recruiting - Clinical trials for Management of Stable Vitiligo

Effect of Platelet Rich Plasma on Outcome of Narrow Band UVB in Treatment of Vitiligo; Clinical and Histopathological Study

Start date: December 8, 2023
Phase: N/A
Study type: Interventional

For each patient, one side of body will be treated with NB-UVB alone while the other side will be treated with NB-UVB therapy in addition to intradermal injection of PRP every 2 weeks. Patients will be photographed at the first visit, in the middle and at the end of therapy. Each patient will sign a written consent form to be included in the study and to be photographed.

NCT ID: NCT06369662 Active, not recruiting - Clinical trials for Acute Myeloid Leukemia

CD155 Expression in Acute Myeloid Leukemia

Start date: July 1, 2022
Phase:
Study type: Observational [Patient Registry]

Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy. It is the most common form of acute leukemia among adults. In the United States, an estimated 19,940 people will be diagnosed with AML in 2020. CD155 expression was associated with an unfavorable prognosis in solid tumors such as colon cancer, breast cancer, lung adenocarcinoma, pancreatic cancer, melanoma, and glioblastoma, as it correlated with tumor migration, development of metastases, tissue and lymph node invasion, relapse, and poorer survival.

NCT ID: NCT06360601 Active, not recruiting - Preeclampsia Severe Clinical Trials

Intravenous Labetalol Versus Hydralazine in Preeclampsia

Start date: April 1, 2024
Phase: Phase 1/Phase 2
Study type: Interventional

We study the effect of intravenous labetalol versus hydralazine in sever preeclampsia patients on cerebral blood flow and neurological outcome